Acrivon Therapeutics, Inc. · NASDAQ:ACRV

Devroe Eric sold 628 Acrivon Therapeutics, Inc. shares (Form 4)

Traded Nov 17, 2026 · Filed Nov 19, 2026

On Nov 17, 2026, Devroe Eric (Chief Operating Officer) sold 628 Acrivon Therapeutics, Inc. shares at US$1.45 for US$911, leaving 145,721 shares. Filed Nov 19, 2026 (Form 4).

Sold
628 shares
Price
US$1.45
Value
US$911
Holding after
145,721 shares
Trading plan
No
Role
Chief Operating Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 17, 2026Common StockSale628US$1.45145,721Direct

Source

Download original · View original at SEC

Related